News and Press Releases
About the CF Foundation | Get Involved CF Foundation busca la participación de las comunidades afroamericana, latina, indígena, asiática, de Medio Oriente y otras personas de color

Poner atención a la diversidad de voces es fundamental a medida que continuamos con  nuestra meta de escuchar, aprender y actuar contra el racismo y la discriminación.

| 4 min read
About the CF Foundation | Get Involved CF Foundation Seeks Input from Communities of Color

Hearing from diverse voices is critical as we continue our journey to listen, learn, and take action against racism and discrimination.

| 3 min read
CFTR Modulators | About the CF Foundation A Message From Our CEO

The CF Foundation has successfully completed a sale of its remaining stake in royalties related to Vertex's CFTR modulators for an upfront payment of $575 million and a potential future payment of $75 million, bringing additional resources to the fight against CF.

| 3 min read
CFTR Modulators | About the CF Foundation | Clinician Resources CF Foundation Leaders Provide Expertise During ICER Public Meeting

On Aug. 27, leaders from the Cystic Fibrosis Foundation, along with several people from the CF community, participated in a virtual public meeting hosted by the Institute for Clinical and Economic Review to provide insights and expertise on the value of CFTR modulators.

| 3 min read
Research | About the CF Foundation | Our Research Approach CF Foundation Awards Nearly $15 Million to Spur Infection Research

Thirty-three new projects are being funded as part of the Foundation's $100 million Infection Research Initiative.

| 4 min read
Get Involved | About the CF Foundation CF Foundation Announces 2020 Impact Grant Recipients

Recipients include four programs from around the country that engage and empower the CF community.

| 4 min read
Drug Pipeline | About the CF Foundation CF Foundation Awards Leading Research Organization Funding to Screen for Potential B. Cepacia Therapy

The Cystic Fibrosis Foundation awarded nearly $700,000 to Calibr, the drug discovery and development arm of Scripps Research, to screen for a compound that could be used to treat Burkholderia cepacia complex infections. 

| 2 min read